Faculty cover photo

Risha Gidwani

Professor specializing in health economics, Risha Gidwani is an esteemed Adjunct Associate Professor at the University of California-Los Angeles, where she contributes significantly to the field of Health Policy and Management. Her research is primarily centered around evaluating the costs and health outcomes associated with healthcare services, with a particular focus on the impact of benefit design on the quality of care and patient financial burden. Dr. Gidwani has been at the forefront of research as a Principal Investigator on several grants, delving into the value of cancer care and end-of-life care. Her work is pivotal in understanding how healthcare services can be optimized to improve patient outcomes while managing costs effectively. She employs a variety of methodological approaches, including causal inference from observational data and decision analysis, to study the intricate dynamics of health service utilization. In addition to her academic role, Dr. Gidwani is a Senior Policy Researcher at the RAND Corporation, where she applies her expertise to influence health policy and management practices. Her dual roles allow her to bridge the gap between academic research and practical policy implementation, ensuring that her findings have a tangible impact on healthcare systems. Dr. Gidwani's research interests are deeply rooted in health economics, with a keen interest in cancer care, patient financial burden, and end-of-life care. Her work is instrumental in shaping policies that aim to reduce financial strain on patients while maintaining high standards of care. Through her dedication to research and policy, Dr. Gidwani continues to make significant contributions to the field of health economics, influencing both academic discourse and real-world healthcare practices. Her commitment to improving healthcare outcomes and reducing patient financial burdens underscores her role as a leader in health policy and management.

External Link

Publications

Share Risha's Profile